Hint: $TECX

www.subradata.com/abstract/sea...

No problem, if you have any problems, reach out at [email protected] and I’ll take a look (also if anything you want re: features that could be a nice addition I’ll see if I can add)

Check now

Which url? I can fix that pretty quickly usually

I've peaked in life.

I think this bodes well for novel treatments but he will be tougher on medications for large conditions. Rare diseases shouldn't be impacted much (though he should accept increased flexibility, following the recent trends)

Also talks about the microbiome and other new treatments for lifestyle conditions, mentions lipoprotein(a) youtube.com/watch?v=jQk2...

I wonder his GLP impact (touches on this at 28:00 in the pod) He likely understands the benefits but cautions against taking new treatments at face value and is against pharma lobbying/advertising broadly. Also encouraging comments on muscle loss/ways to improve metabolic health

Interesting it’s targeted for muscular dystrophy and preclinical. Compared to farther along rare disease players like rocket and Lexio targeting various cardiac diseases

How does the recent Neurogene failure play into the calculus?

Currently using to post and link to outside sources, but will discuss if engagement increases